down arrow

Lactose (India)

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE058I01013
  • NSEID:
  • BSEID: 524202
INR
107.00
2 (1.9%)
BSENSE

Apr 11, 12:41 PM

BSE+NSE Vol: 43

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Lactose (India) Ltd stock-summary
stock-summary
Lactose (India) Ltd
Micro Cap
Pharmaceuticals & Drugs
Lactose (India) Ltd was incorporated on March 1991 as a Public Limited Company in the Vadodara district of Gujarat. The company is engaged in the manufacturing and trading of pharmaceutical products. They offer edible and pharmaceutical grade lactose, which is used as an ingredient in pharmaceutical products, as well as in the dairy, food, confectionery, and beverage industries. The company also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee.
Company Coordinates stock-summary
Company Details
Survey No 6, Village Poicha (Rania) Savli Vadodara Gujarat : 391780
stock-summary
Tel: 91-02667-244308/244729
stock-summary
investor.lactose@gmail.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 12.59 Cr
Number of Shares
1.26 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
28-Mar-2022
1.26
12.59
342000
10
Conversion of Warrants
11-Dec-2021
1.22
12.25
810000
10
Conversion of Warrants
24-Feb-2021
1.14
11.44
1248000
10
Conversion of Warrants
31-Dec-2018
1.02
10.19
0
10
As Per Shareholding Pattern
31-Dec-2018
1.02
10.19
0
10
As Per Shareholding Pattern
16-Nov-2018
1.02
10.19
150000
10
Conversion of Warrants
16-Nov-2018
1.02
10.19
150000
10
Conversion of Warrants
20-Mar-2018
1
10.04
190200
10
Conversion of Warrants
23-Jan-2018
98.49
9.85
169800
10
Conversion of Warrants
21-Dec-2016
96.79
9.68
420000
10
Conversion of Warrants
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

26.0693

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Sangita Maheshwari (30.73%)

Highest Public shareholder

Madhusha Holdings Private Limited (3.97%)

Individual Investors Holdings

38.08%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Atul Maheshwari
Chairman & Managing Director
95.78 lacs
S M Maheshwari
Whole Time Director & CFO
52.67 lacs
Pramod Kalani
Independent Non Exe. Director
0
G K Sarda
Independent Non Exe. Director
0
Dhaval J Soni
Independent Non Exe. Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Conversion Charges
25.92
83.27%
Lactulose
4.53
14.54%
Manufacturing Consideration
0.58
1.86%
 
83.27
Conversion Charges
16.73
Conversion Charges
14.54
Lactulose
85.45
Lactulose
1.86
Manufacturing Consideration
98.14
Manufacturing Consideration
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
29 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 148 Cr (Micro Cap)

stock-summary
P/E

21.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.83

stock-summary
Return on Equity

13.46%

stock-summary
Price to Book

2.88